Get Exclusive Offers! Join our VIP text list for special promotions & wellness tips|También hablamos español

Sign Up
HomeBlogSemaglutide vs Ozempic vs Wegovy
GLP-1 Explained

Semaglutide vs Ozempic vs Wegovy: What's the Difference? (Miami Guide)

March 25, 202510 min readBy B12 Injections Miami Medical Team
Semaglutide vs Ozempic vs Wegovy comparison

The Short Answer

Semaglutide, Ozempic, and Wegovy are all the same drug — just different brand names and doses. Understanding the differences helps you make the right choice for your weight loss goals in Miami.

If you have been researching medical weight loss in Miami, you have almost certainly come across a confusing trifecta of names: Semaglutide, Ozempic, and Wegovy. Patients ask us this question every single day: “Are these the same thing? Which one should I be on?” This guide answers those questions definitively — and helps you understand exactly what you are getting at our Sweetwater weight loss clinic.

The Core Answer: It's All Semaglutide

Semaglutide is the generic name of a GLP-1 receptor agonist molecule developed by Danish pharmaceutical company Novo Nordisk. This single molecule has been packaged, approved by the FDA, and marketed under multiple brand names for different medical purposes:

Ozempic
Semaglutide
Indication: FDA-approved for Type 2 Diabetes
Max dose: 2mg / week
Avg weight loss: ~10–12% avg

Often prescribed off-label for weight loss when Wegovy is unavailable

Wegovy
Semaglutide
Indication: FDA-approved for Chronic Weight Management
Max dose: 2.4mg / week
Avg weight loss: ~14.9% avg

Higher dose specifically approved for weight loss — the gold standard

Rybelsus
Semaglutide (oral)
Indication: FDA-approved for Type 2 Diabetes (oral)
Max dose: 14mg / day (oral)
Avg weight loss: ~5–7% avg

Oral tablet form — lower bioavailability, less weight loss than injectable

Why Does the Dose Matter So Much?

The critical difference between Ozempic and Wegovy is the maintenance dose. Wegovy's 2.4mg weekly dose was specifically studied and FDA-approved for weight management. Clinical trials (the STEP program) demonstrated that this higher dose produces significantly greater weight reduction than the lower doses used in Ozempic for diabetes.

Think of it this way: both medications contain the same drug, but Wegovy is loaded at a higher dose that more powerfully suppresses appetite and improves metabolic function. It is the same reason why 400mg of ibuprofen handles mild pain while 800mg is needed for more serious inflammation — same molecule, different dose, different effect.

Weight Loss by Semaglutide Dose — STEP Trials

Wegovy 2.4mg/week
14.9%
Ozempic 2.0mg/week (off-label)
11.6%
Ozempic 1.0mg/week
8.8%
Ozempic 0.5mg/week
6.1%
Rybelsus 14mg/day (oral)
5.3%

Ozempic Off-Label for Weight Loss: Is It Legal?

Absolutely yes. In the United States, once a drug is FDA-approved, physicians are legally permitted to prescribe it “off-label” for other conditions. Since Ozempic and Wegovy contain identical molecules, prescribing Ozempic for weight loss is both legal and medically supported.

Why would a doctor prescribe Ozempic instead of Wegovy for weight loss?

  • Insurance coverage: Many insurers cover Ozempic for diabetes but not Wegovy for weight loss — prescribing off-label can reduce patient cost dramatically
  • Shortage situations: When Wegovy is on backorder or allocation, Ozempic provides the same active ingredient
  • Comorbid conditions: Patients with both diabetes and obesity may benefit from Ozempic's dual diabetes + weight management effects
  • Dose preference: Some patients achieve their goal weight at lower doses and do not need to escalate to 2.4mg

How Does Semaglutide Compare to Tirzepatide (Mounjaro / Zepbound)?

This is the next logical question, and it is an important one for Miami patients evaluating GLP-1 options. Tirzepatide is a newer medication (also injectable, also weekly) that activates both GLP-1 and GIP receptors, producing even greater average weight loss.

FeatureSemaglutide (Wegovy)Tirzepatide (Zepbound)
MechanismGLP-1 agonistDual GLP-1 + GIP agonist
Brand namesOzempic, WegovyMounjaro, Zepbound
FDA approval (weight)Wegovy 2.4mg (2021)Zepbound (2023)
Max weekly dose2.4mg15mg
Avg weight loss~14.9%~20.9%
CV benefit dataSELECT trial: 20% CV risk reductionEmerging data (positive)
Years on market~7 years (Ozempic since 2017)~2 years (Mounjaro since 2022)
Side effectsNausea, constipation, GISimilar; slightly more GI at high dose

Which Medication Is Right for You?

Consider Semaglutide (Wegovy/Ozempic) If:

  • You have cardiovascular disease (proven 20% CV risk reduction)
  • You also have Type 2 diabetes
  • Your insurance covers Ozempic but not Zepbound
  • You prefer a medication with 7+ years of safety data
  • A 15% weight loss goal is sufficient for you

Consider Tirzepatide (Zepbound/Mounjaro) If:

  • You want maximum weight loss potential (20%+ average)
  • You have insulin resistance or prediabetes
  • You have not achieved desired results on semaglutide
  • Your insurance covers Zepbound
  • You are comfortable with a newer medication with excellent but shorter data

Getting Semaglutide, Ozempic, or Wegovy in Miami

At B12 Injections Miami in Sweetwater, we prescribe and supervise both semaglutide (Wegovy / Ozempic) and tirzepatide (Zepbound / Mounjaro) for medical weight loss. Our process is straightforward:

  1. Complete our online intake form — takes about 15 minutes and covers your medical history
  2. Medical evaluation — our board-certified provider reviews your history, checks contraindications, and recommends the right medication and starting dose
  3. Prescription + injection training — we teach you how to self-administer at home (it is easier than you think)
  4. Monthly follow-up — we monitor labs, adjust doses, and track your progress throughout

We serve all Miami-Dade neighborhoods: Doral, Kendall, Hialeah, Westchester, Sweetwater, Coral Gables, South Miami, Tamiami, Fontainebleau, Medley, and more. Same-day and next-day appointments are often available.

Frequently Asked Questions

Is Ozempic the same as Semaglutide?

Yes. Ozempic IS Semaglutide — they are the exact same molecule (semaglutide). Ozempic is the brand name manufactured by Novo Nordisk, approved by the FDA specifically for Type 2 diabetes management at doses up to 2mg weekly.

What is the difference between Ozempic and Wegovy?

Ozempic and Wegovy are both brand names for semaglutide — the difference is the approved dose and FDA indication. Ozempic is approved for Type 2 diabetes (max dose 2mg/week). Wegovy is approved specifically for chronic weight management at a higher dose of 2.4mg/week.

Can I use Ozempic for weight loss even though it's approved for diabetes?

Yes — prescribing Ozempic off-label for weight loss is legal and common. Many providers prescribe it when Wegovy is unavailable or when insurance only covers the diabetes indication. At our Miami clinic, we work with each patient's insurance to find the right option.

Does Wegovy work better than Ozempic for weight loss?

Wegovy (2.4mg semaglutide) produces better weight loss results than Ozempic (max 2mg) because of the higher maintenance dose. Clinical trials for Wegovy showed an average of 14.9% body weight reduction over 68 weeks.

Where can I get Semaglutide, Ozempic, or Wegovy in Miami?

B12 Injections Miami in Sweetwater provides medically supervised Semaglutide and GLP-1 weight loss programs. We serve all Miami-Dade neighborhoods including Doral, Kendall, Hialeah, and Westchester. Call (305) 490-2240 or complete our online intake form.

How does Semaglutide compare to Tirzepatide (Mounjaro/Zepbound) for weight loss?

Tirzepatide activates two hormone receptors (GLP-1 + GIP) instead of one, producing greater average weight loss — approximately 20.9% vs 14.9% for semaglutide. Both are excellent; tirzepatide tends to produce more weight loss while semaglutide has longer real-world safety data and proven cardiovascular benefits.

What are the side effects of Semaglutide / Ozempic / Wegovy?

The most common side effects are gastrointestinal: nausea, constipation, diarrhea, and decreased appetite. These typically occur during dose escalation and improve over time. A thorough medical evaluation is required before starting any GLP-1 medication.

Start Your Semaglutide Journey in Miami

Board-certified providers. Transparent pricing. In-person care in Sweetwater, FL. Serving all Miami-Dade neighborhoods.

Chat with us on WhatsApp

Hablamos español también 🇺🇸🇨🇺🇲🇽